619 results on '"J Hinrichs"'
Search Results
2. How legal problems are conceptualized and measured in healthcare settings: a systematic review
- Author
-
Joshua R. Vest, Rachel J. Hinrichs, and Heidi Hosler
- Subjects
Social determinants of health ,Screening ,Measurement ,Public aspects of medicine ,RA1-1270 ,Social pathology. Social and public welfare. Criminology ,HV1-9960 - Abstract
Abstract Legal problems encompass issues requiring resolution through the justice system. This social risk factor creates barriers in accessing services and increases risk of poor health outcomes. A systematic review of the peer-reviewed English-language health literature following the PRISMA guidelines sought to answer the question, how has the concept of patients’ “legal problems” been operationalized in healthcare settings? Eligible articles reported the measurement or screening of individuals for legal problems in a United States healthcare or clinical setting. We abstracted the prevalence of legal problems, characteristics of the sampled population, and which concepts were included. 58 studies reported a total of 82 different measurements of legal problems. 56.8% of measures reflected a single concept (e.g., incarcerated only). The rest of the measures reflected two or more concepts within a single reported measure (e.g., incarcerations and arrests). Among all measures, the concept of incarceration or being imprisoned appeared the most frequently (57%). The mean of the reported legal problems was 26%. The literature indicates that legal concepts, however operationalized, are very common among patients. The variation in measurement definitions and approaches indicates the potential difficulties for organizations seeking to address these challenges.
- Published
- 2023
- Full Text
- View/download PDF
3. Combinations of arginine and pullulan reveal the selective effect of stabilization mechanisms on different lyophilized proteins
- Author
-
T. T. Nguyen, Khanh, Zillen, Daan, Lasorsa, Alessia, van der Wel, Patrick C.A., Frijlink, Henderik W., and L. J. Hinrichs, Wouter
- Published
- 2024
- Full Text
- View/download PDF
4. Privacy and Security Perceptions in Augmented Cognition Applications.
- Author
-
Michael-Brian Ogawa, Brent Auernheimer, Barbara Endicott-Popovsky, Randy J. Hinrichs, and Martha E. Crosby
- Published
- 2023
- Full Text
- View/download PDF
5. Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
- Author
-
Rick Heida, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
respiratory viruses ,mucosal immunity ,antiviral agents ,inhalation ,vaccines ,dry powder formulation ,Microbiology ,QR1-502 - Abstract
ABSTRACT Many of the current pandemic threats are caused by viruses that infect the respiratory tract. Remarkably though, the majority of vaccines and antiviral drugs are administered via alternative routes. In this perspective, we argue that the pulmonary route of administration deserves more attention in the search for novel therapeutic strategies against respiratory virus infections. Firstly, vaccines administered at the viral portal of entry can induce a broader immune response, employing the mucosal arm of the immune system; secondly, direct administration of antiviral drugs at the target site leads to superior bioavailability, enabling lower dosing and reducing the chance of side effects. We further elaborate on why the pulmonary route may induce a superior effect compared to the intranasal route of administration and provide reasons why dry powder formulations for inhalation have significant advantages over standard liquid formulations.
- Published
- 2023
- Full Text
- View/download PDF
6. Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings
- Author
-
Khanh T. T. Nguyen, Daan Zillen, Franca F. M. van Heijningen, Kjeld J. C. van Bommel, Renz J. van Ee, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
3D printing ,powder bed printing ,personalized medicine ,biologics ,formulation ,surface analysis ,Pharmacy and materia medica ,RS1-441 - Abstract
In a previous attempt to achieve ileo-colonic targeting of bovine intestinal alkaline phosphatase (BIAP), we applied a pH-dependent coating, the ColoPulse coating, directly on powder bed printed (PBP) tablets. However, the high surface roughness necessitated an additional sub-coating layer [Nguyen, K. T. T., Pharmaceutics 2022]. In this study, we aimed to find a production method for PBP tablets containing BIAP that allows the direct application of coating systems. Alterations of the printing parameters, binder content, and printing layer height, when combined, were demonstrated to create visually less rough PBP tablets. The addition of ethanol vapor treatment further improved the surface’s smoothness significantly. These changes enabled the direct application of the ColoPulse, or enteric coating, without a sub-coating. In vitro release testing showed the desired ileo-colonic release or upper-intestinal release for ColoPulse or enteric-coated tablets, respectively. Tablets containing BIAP, encapsulated within an inulin glass, maintained a high enzymatic activity (over 95%) even after 2 months of storage at 2–8 °C. Importantly, the coating process did not affect the activity of BIAP. In this study, we demonstrate, for the first time, the successful production of PBP tablets with surfaces that are directly coatable with the ColoPulse coating while preserving the stability of the encapsulated biopharmaceutical, BIAP.
- Published
- 2023
- Full Text
- View/download PDF
7. RANKL confers protection against cell death in precision-cut lung slices
- Author
-
M. J. R. Ruigrok, M. A. P. Roest, H. W. Frijlink, P. Olinga, W. L. J. Hinrichs, and B. N. Melgert
- Subjects
chronic bronchitis ,emphysema ,explant culture ,OPGL ,tissue regeneration ,TRANCE ,Physiology ,QP1-981 - Abstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally and constitutes a major health problem. The disease is characterized by airflow obstructions due to chronic bronchitis and/or emphysema. Emerging evidence suggests that COPD is the result of impaired epithelial repair. Motivated by the need for more effective treatments, we studied whether receptor activator of nuclear factor κ-Β ligand (RANKL) contributed to epithelial repair, as this protein has been implicated in epithelial regeneration of breast and thymus. To do so, we used precision-cut lung slices prepared from mouse tissue—viable explants that can be cultured ex vivo for up to a few days while retaining features of lung tissue. Slices were cultured with 10, 100, or 500 ng/ml of mouse RANKL for 24 h. We first found RANKL activated nuclear factor κ-Β signaling, which is involved in cellular stress responses, without affecting the general viability of slices. Cell proliferation, however, was not altered by RANKL treatment. Interestingly, RANKL did reduce cell death, as revealed by TUNEL stainings and profiling of apoptosis-related proteins, indicating that it contributes to repair by conferring protection against cell death. This study improves our understanding of lung repair and could create new opportunities for developing COPD treatments.
- Published
- 2022
- Full Text
- View/download PDF
8. Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
- Author
-
Rick Heida, Paul Hagedoorn, Melle C. van Meel, Jurrie E. R. Prins, Frederike S. Simonis, Renate Akkerman, Anke L. W. Huckriede, Henderik W. Frijlink, Anne H. de Boer, and Wouter L. J. Hinrichs
- Subjects
in vivo ,pulmonary administration ,dry powder formulations ,spray drying ,intratracheal administration ,inhalation ,Pharmacy and materia medica ,RS1-441 - Abstract
A challenge in the development of dry powder formulations for inhalation is the poor reproducibility of their administration to small laboratory animals. The currently used devices for the pulmonary administration of dry powder formulations to small rodents often function sub-optimally as they use the same puff of air for both powder dispersion and aerosol delivery. As a result, either the air volume and flow rate are too low for complete powder deagglomeration or they are too high for effective aerosol delivery to the lungs of the animal. Therefore, novel and better devices are desired. We here present an aerosol generator designed to administer a pre-generated aerosol to the lungs of mice. By mapping the complex relationship between the airflow rate, delivery time and emitted dose, we were able to control the amount of powder being delivered from the aerosol generator. The emitted aerosol had a size range favorable for lung deposition and could be measured reproducibly. Nevertheless, in vivo fluorescent imaging still revealed considerable differences between the mice in terms of the dose deposited and the distribution of powder over the lungs, suggesting that a certain biological variation in lung deposition is inevitable.
- Published
- 2023
- Full Text
- View/download PDF
9. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review
- Author
-
Primawan Putra Nugrahadi, Wouter L. J. Hinrichs, Henderik W. Frijlink, Christian Schöneich, and Christina Avanti
- Subjects
therapeutic peptides ,stabilization formulations ,aqueous solutions ,Pharmacy and materia medica ,RS1-441 - Abstract
Over the past few decades, there has been a tremendous increase in the utilization of therapeutic peptides. Therapeutic peptides are usually administered via the parenteral route, requiring an aqueous formulation. Unfortunately, peptides are often unstable in aqueous solutions, affecting stability and bioactivity. Although a stable and dry formulation for reconstitution might be designed, from a pharmaco-economic and practical convenience point of view, a peptide formulation in an aqueous liquid form is preferred. Designing formulation strategies that optimize peptide stability may improve bioavailability and increase therapeutic efficacy. This literature review provides an overview of various degradation pathways and formulation strategies to stabilize therapeutic peptides in aqueous solutions. First, we introduce the major peptide stability issues in liquid formulations and the degradation mechanisms. Then, we present a variety of known strategies to inhibit or slow down peptide degradation. Overall, the most practical approaches to peptide stabilization are pH optimization and selecting the appropriate type of buffer. Other practical strategies to reduce peptide degradation rates in solution are the application of co-solvency, air exclusion, viscosity enhancement, PEGylation, and using polyol excipients.
- Published
- 2023
- Full Text
- View/download PDF
10. A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice
- Author
-
Renée S. van der Kooij, Martin Beukema, Anke L. W. Huckriede, Johan Zuidema, Rob Steendam, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
bovine serum albumin ,immune response ,monolithic microspheres ,multi-block copolymer ,single-injection vaccine ,sustained release ,Pharmacy and materia medica ,RS1-441 - Abstract
Although vaccination is still considered to be the cornerstone of public health care, the increase in vaccination coverage has stagnated for many diseases. Most of these vaccines require two or three doses to be administered across several months or years. Single-injection vaccine formulations are an effective method to overcome the logistical barrier to immunization that is posed by these multiple-injection schedules. Here, we developed subcutaneously (s.c.) injectable microspheres with a sustained release of the model antigen bovine serum albumin (BSA). The microspheres were composed of blends of two novel biodegradable multi-block copolymers consisting of amorphous, hydrophilic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) (PCL-PEG-PCL) blocks and semi-crystalline poly(dioxanone) (PDO) blocks of different block sizes. In vitro studies demonstrated that the release of BSA could be tailored over a period of approximately four to nine weeks by changing the blend ratio of both polymers. Moreover, it was found that BSA remained structurally intact during release. Microspheres exhibiting sustained release of BSA for six weeks were selected for the in vivo study in mice. The induced BSA-specific IgG antibody titers increased up to four weeks after administration and were of the same magnitude as found in mice that received a priming and a booster dose of BSA in phosphate-buffered saline (PBS). Determination of the BSA concentration in plasma showed that in vivo release probably took place up to at least four weeks, although plasma concentrations peaked already one week after administration. The sustained-release microspheres might be a viable alternative to the conventional prime-boost immunization schedule, but a clinically relevant antigen should be incorporated to assess the full potential of these microspheres in practice.
- Published
- 2023
- Full Text
- View/download PDF
11. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
- Author
-
Clare A. Aitken, Heleen M. E. van Agt, Albert G. Siebers, Folkert J. van Kemenade, Hubert G. M. Niesters, Willem J. G. Melchers, Judith E. M. Vedder, Rob Schuurman, Adriaan J. C. van den Brule, Hans C. van der Linden, John W. J. Hinrichs, Anco Molijn, Klaas J. Hoogduin, Bettien M. van Hemel, and Inge M. C. M. de Kok
- Subjects
Cervical cancer screening ,hrHPV screening ,Population-based screening ,Cancer screening programmes ,Medicine - Abstract
Abstract Background In January 2017, the Dutch cervical cancer screening programme transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening, including the introduction of self-sampling, for women aged between 30 and 60 years. The Netherlands was the first country to switch to hrHPV screening at the national level. We investigated the health impact of this transition by comparing performance indicators from the new hrHPV-based programme with the previous cytology-based programme. Methods We obtained data from the Dutch nationwide network and registry of histo- and cytopathology (PALGA) for 454,573 women eligible for screening in 2017 who participated in the hrHPV-based programme between 1 January 2017 and 30 June 2018 (maximum follow-up of almost 21 months) and for 483,146 women eligible for screening in 2015 who participated in the cytology-based programme between 1 January 2015 and 31 March 2016 (maximum follow-up of 40 months). We compared indicators of participation (participation rate), referral (screen positivity; referral rate) and detection (cervical intraepithelial neoplasia (CIN) detection; number of referrals per detected CIN lesion). Results Participation in the hrHPV-based programme was significantly lower than that in the cytology-based programme (61% vs 64%). Screen positivity and direct referral rates were significantly higher in the hrHPV-based programme (positivity rate: 5% vs 9%; referral rate: 1% vs 3%). CIN2+ detection increased from 11 to 14 per 1000 women screened. Overall, approximately 2.2 times more clinical irrelevant findings (i.e. ≤CIN1) were found in the hrHPV-based programme, compared with approximately 1·3 times more clinically relevant findings (i.e. CIN2+); this difference was mostly due to a national policy change recommending colposcopy, rather than observation, of hrHPV-positive, ASC-US/LSIL results in the hrHPV-based programme. Conclusions This is the first time that comprehensive results of nationwide implementation of hrHPV-based screening have been reported using high-quality data with a long follow-up. We have shown that both benefits and potential harms are higher in one screening round of a well-implemented hrHPV-based screening programme than in an established cytology-based programme. Lower participation in the new hrHPV programme may be due to factors such as invitation policy changes and the phased roll-out of the new programme. Our findings add further to evidence from trials and modelling studies on the effectiveness of hrHPV-based screening.
- Published
- 2019
- Full Text
- View/download PDF
12. The publication fate of abstracts presented at the Medical Library Association conferences
- Author
-
Rachel J. Hinrichs, Mirian Ramirez, and Mahasin Ameen
- Subjects
publishing ,congresses as topic ,libraries ,medical ,health sciences librarians ,Bibliography. Library science. Information resources ,Medicine - Abstract
Objective: We sought to determine how many abstracts presented at the 2012 and 2014 Medical Library Association (MLA) annual conferences were later published as full-text journal articles and which features of the abstract and first author influence the likelihood of future publication. To do so, we replicated a previous study on MLA conference abstracts presented in 2002 and 2003. The secondary objective was to compare the publication rates between the prior and current study. Methods: Presentations and posters delivered at the 2012 and 2014 MLA meetings were coded to identify factors associated with publication. Postconference publication of abstracts as journal articles was determined using a literature search and survey sent to first authors. Chi-squared tests were used to assess differences in the publication rate, and logistic regression was used to assess the influence of abstract factors on publication. Results: The combined publication rate for the 2012 and 2014 meetings was 21.8% (137/628 abstracts), which is a statistically significant decrease compared to the previously reported rate for 2002 and 2003 (27.6%, 122/442 abstracts). The odds that an abstract would later be published as a journal article increased if the abstract was multi-institutional or if it was research, specifically surveys or mixed methods research. Conclusions: The lower publication rate of MLA conference abstracts may be due to an increased number of program or nonresearch abstracts that were accepted or a more competitive peer review process for journals. MLA could increase the publication rate by encouraging and enabling multi-institutional research projects among its members.
- Published
- 2021
- Full Text
- View/download PDF
13. Effect of dietary nitrate on human muscle power: a systematic review and individual participant data meta-analysis
- Author
-
Andrew R. Coggan, Marissa N. Baranauskas, Rachel J. Hinrichs, Ziyue Liu, and Stephen J. Carter
- Subjects
dietary nitrate ,nitric oxide ,muscle power ,humans ,individual participant data ,Nutrition. Foods and food supply ,TX341-641 ,Sports medicine ,RC1200-1245 - Abstract
Background Previous narrative reviews have concluded that dietary nitrate (NO3 −) improves maximal neuromuscular power in humans. This conclusion, however, was based on a limited number of studies, and no attempt has been made to quantify the exact magnitude of this beneficial effect. Such information would help ensure adequate statistical power in future studies and could help place the effects of dietary NO3 − on various aspects of exercise performance (i.e., endurance vs. strength vs. power) in better context. We therefore undertook a systematic review and individual participant data meta-analysis to quantify the effects of NO3 − supplementation on human muscle power. Methods The literature was searched using a strategy developed by a health sciences librarian. Data sources included Medline Ovid, Embase, SPORTDiscus, Scopus, Clinicaltrials.gov, and Google Scholar. Studies were included if they used a randomized, double-blind, placebo-controlled, crossover experimental design to measure the effects of dietary NO3 − on maximal power during exercise in the non-fatigued state and the within-subject correlation could be determined from data in the published manuscript or obtained from the authors. Results Nineteen studies of a total of 268 participants (218 men, 50 women) met the criteria for inclusion. The overall effect size (ES; Hedge’s g) calculated using a fixed effects model was 0.42 (95% confidence interval (CI) 0.29, 0.56; p = 6.310 × 10− 11). There was limited heterogeneity between studies (i.e., I2 = 22.79%, H2 = 1.30, p = 0.3460). The ES estimated using a random effects model was therefore similar (i.e., 0.45, 95% CI 0.30, 0.61; p = 1.064 × 10− 9). Sub-group analyses revealed no significant differences due to subject age, sex, or test modality (i.e., small vs. large muscle mass exercise). However, the ES in studies using an acute dose (i.e., 0.54, 95% CI 0.37, 0.71; p = 6.774 × 10− 12) was greater (p = 0.0211) than in studies using a multiple dose regimen (i.e., 0.22, 95% CI 0.01, 0.43; p = 0.003630). Conclusions Acute or chronic dietary NO3 − intake significantly increases maximal muscle power in humans. The magnitude of this effect–on average, ~ 5%–is likely to be of considerable practical and clinical importance.
- Published
- 2021
- Full Text
- View/download PDF
14. Formulation of a 3D Printed Biopharmaceutical: The Development of an Alkaline Phosphatase Containing Tablet with Ileo-Colonic Release Profile to Treat Ulcerative Colitis
- Author
-
Khanh T. T. Nguyen, Franca F. M. Heijningen, Daan Zillen, Kjeld J. C. van Bommel, Renz J. van Ee, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
3D printing ,powder bed printing ,personalized medicine ,biologics ,formulation ,ileo-colonic targeting ,Pharmacy and materia medica ,RS1-441 - Abstract
Powder bed printing is a 3D-printing process that creates freeform geometries from powders, with increasing traction for personalized medicine potential. Little is known about its applications for biopharmaceuticals. In this study, the production of tablets containing alkaline phosphatase using powder bed printing for the potential treatment of ulcerative colitis (UC) was investigated, as was the coating of these tablets to obtain ileo-colonic targeting. The printing process was studied, revealing line spacing as a critical factor affecting tablet physical properties when using hydroxypropyl cellulose as the binder. Increasing line spacing yielded tablets with higher porosity. The enzymatic activity of alkaline phosphatase (formulated in inulin glass) remained over 95% after 2 weeks of storage at 45 °C. The subsequent application of a colonic targeting coating required a PEG 1500 sub-coating. In vitro release experiments, using a gastrointestinal simulated system, indicated that the desired ileo-colonic release was achieved. Less than 8% of the methylene blue, a release marker, was released in the terminal ileum phase, followed by a fast release in the colon phase. No significant impact from the coating process on the enzymatic activity was found. These tablets are the first to achieve both biopharmaceutical incorporation in powder bed printed tablets and ileo-colonic targeting, thus might be suitable for on-demand patient-centric treatment of UC.
- Published
- 2022
- Full Text
- View/download PDF
15. ELQ-331 as a prototype for extremely durable chemoprotection against malaria
- Author
-
Martin J. Smilkstein, Sovitj Pou, Alina Krollenbrock, Lisa A. Bleyle, Rozalia A. Dodean, Lisa Frueh, David J. Hinrichs, Yuexin Li, Thomas Martinson, Myrna Y. Munar, Rolf W. Winter, Igor Bruzual, Samantha Whiteside, Aaron Nilsen, Dennis R. Koop, Jane X. Kelly, Stefan H. I. Kappe, Brandon K. Wilder, and Michael K. Riscoe
- Subjects
Malaria ,Plasmodium ,Chemoprotection ,Chemoprevention ,Prophylaxis ,Intra-muscular ,Arctic medicine. Tropical medicine ,RC955-962 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The potential benefits of long-acting injectable chemoprotection (LAI-C) against malaria have been recently recognized, prompting a call for suitable candidate drugs to help meet this need. On the basis of its known pharmacodynamic and pharmacokinetic profiles after oral dosing, ELQ-331, a prodrug of the parasite mitochondrial electron transport inhibitor ELQ-300, was selected for study of pharmacokinetics and efficacy as LAI-C in mice. Methods Four trials were conducted in which mice were injected with a single intramuscular dose of ELQ-331 or other ELQ-300 prodrugs in sesame oil with 1.2% benzyl alcohol; the ELQ-300 content of the doses ranged from 2.5 to 30 mg/kg. Initial blood stage challenges with Plasmodium yoelii were used to establish the model, but the definitive study measure of efficacy was outcome after sporozoite challenge with a luciferase-expressing P. yoelii, assessed by whole-body live animal imaging. Snapshot determinations of plasma ELQ-300 concentration ([ELQ-300]) were made after all prodrug injections; after the highest dose of ELQ-331 (equivalent to 30 mg/kg ELQ-300), both [ELQ-331] and [ELQ-300] were measured at a series of timepoints from 6 h to 5½ months after injection. Results A single intramuscular injection of ELQ-331 outperformed four other ELQ-300 prodrugs and, at a dose equivalent to 30 mg/kg ELQ-300, protected mice against challenge with P. yoelii sporozoites for at least 4½ months. Pharmacokinetic evaluation revealed rapid and essentially complete conversion of ELQ-331 to ELQ-300, a rapidly achieved (
- Published
- 2019
- Full Text
- View/download PDF
16. One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides
- Author
-
Shivanand O. Richardson, Manon M. H. Huibers, Roel A. de Weger, Wendy W. J. de Leng, John W. J. Hinrichs, Ruud W. J. Meijers, Stefan M. Willems, and Ton L. M. G. Peeters
- Subjects
Fluorescence In Situ Hybridization ,FISH ,Pretreatment ,Formalin-fixed paraffin-embedded ,Fresh frozen ,Cytological ,Genetics ,QH426-470 - Abstract
Abstract Background The Fluorescence In Situ Hybridization (FISH) technique is a very useful tool for diagnostic and prognostic purposes in molecular pathology. However, clinical testing on patient tissue is challenging due to variables of tissue processing that can influence the quality of the results. This emphasizes the necessity of a standardized FISH protocol with a high hybridization efficiency. We present a pretreatment protocol that is easy, reproducible, cost-effective, and facilitates FISH on all types of patient material simultaneously with good quality results. During validation, FISH analysis was performed simultaneously on formalin-fixed paraffin-embedded, fresh frozen and cytological patient material in combination with commercial probes using our optimized one-fits-all pretreatment protocol. An optimally processed sample is characterized by strong specific signals, intact nuclear membranes, non-disturbing autofluorescence and a homogeneous DAPI staining. Results In our retrospective cohort of 3881 patient samples, overall 93% of the FISH samples displayed good quality results leading to a patient diagnosis. All FISH were assessed on quality aspects such as adequacy and consistency of signal strength (brightness), lack of background and / or cross-hybridization signals, and additionally the presence of appropriate control signals were evaluated to assure probe accuracy. In our analysis 38 different FISH probes from 3 commercial manufacturers were used (Cytocell, Vysis and ZytoLight). The majority of the patients in this cohort displayed good signal quality and barely non-specific background fluorescence on all tissue types independent of which commercial probe was used. Conclusion The optimized one-fits-all FISH method is robust, reliable and reproducible to deliver an accurate result for patient diagnostics in a lean workflow and cost-effective manner. This protocol can be used for widespread application in cancer and non-cancer diagnostics and research.
- Published
- 2019
- Full Text
- View/download PDF
17. Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro
- Author
-
Rick Heida, Philip A. Born, Gabriela Tapia-Calle, Henderik W. Frijlink, Anna Salvati, Anke L. W. Huckriede, and Wouter L. J. Hinrichs
- Subjects
dendritic cells ,drug delivery systems ,flow cytometry ,hepatitis B virus ,human peripheral blood mononuclear cells ,influenza virus ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Viral subunit vaccines are a safer and more tolerable alternative to whole inactivated virus vaccines. However, they often come with limited efficacy, necessitating the use of adjuvants. Using free and particle-bound viral antigens, we assessed whether size affects the uptake of those antigens by human monocyte-derived dendritic cells (Mo-DCs) and whether differences in uptake affect their capacity to stimulate cytokine production by T cells. To this end, influenza antigens and hepatitis B surface antigen (HBsAg) were covalently conjugated to polystyrene particles of 500 nm and 3 μm. Cellular uptake of the antigens, either unconjugated or conjugated, and their capacity to stimulate T cells within a population of human peripheral blood mononuclear cells (PBMCs) were measured by flow cytometry. Conjugation of both antigens to particles significantly increased their uptake by Mo-DCs. Moreover, both the 500 nm and 3 μm influenza conjugates induced significantly higher numbers of cytokine-producing CD4+ T cells and induced increased production of the pro-inflammatory cytokines IFNγ and TNFα. In contrast, conjugation of HBsAg to particles did not notably affect the T cell response. In conclusion, conjugation of antigen to 500 nm and 3 μm particles leads to increased antigen uptake by human Mo-DCs, although the capacity of such conjugates to induce T cell stimulation likely depends on the immunological status of the PBMC donor.
- Published
- 2022
- Full Text
- View/download PDF
18. Non‐Toxic Virucidal Macromolecules Show High Efficacy Against Influenza Virus Ex Vivo and In Vivo
- Author
-
Ozgun Kocabiyik, Valeria Cagno, Paulo Jacob Silva, Yong Zhu, Laura Sedano, Yoshita Bhide, Joelle Mettier, Chiara Medaglia, Bruno Da Costa, Samuel Constant, Song Huang, Laurent Kaiser, Wouter L. J. Hinrichs, Anke Huckriede, Ronan Le Goffic, Caroline Tapparel, and Francesco Stellacci
- Subjects
3’SLN ,6’SLN ,antivirals ,Influenza ,virucidal ,Science - Abstract
Abstract Influenza is one of the most widespread viral infections worldwide and represents a major public health problem. The risk that one of the next pandemics is caused by an influenza strain is high. It is important to develop broad‐spectrum influenza antivirals to be ready for any possible vaccine shortcomings. Anti‐influenza drugs are available but they are far from ideal. Arguably, an ideal antiviral should target conserved viral domains and be virucidal, that is, irreversibly inhibit viral infectivity. Here, a new class of broad‐spectrum anti‐influenza macromolecules is described that meets these criteria and display exceedingly low toxicity. These compounds are based on a cyclodextrin core modified on its primary face with long hydrophobic linkers terminated either in 6'sialyl‐N‐acetyllactosamine (6’SLN) or in 3’SLN. SLN enables nanomolar inhibition of the viruses while the hydrophobic linkers confer irreversibility to the inhibition. The combination of these two properties allows for efficacy in vitro against several human or avian influenza strains, as well as against a 2009 pandemic influenza strain ex vivo. Importantly, it is shown that, in mice, one of the compounds provides therapeutic efficacy when administered 24 h post‐infection allowing 90% survival as opposed to no survival for the placebo and oseltamivir.
- Published
- 2021
- Full Text
- View/download PDF
19. Silencing Heat Shock Protein 47 (HSP47) in Fibrogenic Precision-Cut Lung Slices: A Surprising Lack of Effects on Fibrogenesis?
- Author
-
Mitchel J. R. Ruigrok, Khaled E. M. El Amasi, Diana J. Leeming, Jannie M. B. Sand, Henderik W. Frijlink, Wouter L. J. Hinrichs, and Peter Olinga
- Subjects
collagen chaperone ,Gp46 ,gene silencing ,HSP-47 ,lung explant culture ,lung fibrosis ,Medicine (General) ,R5-920 - Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic disease that is characterized by the excessive deposition of scar tissue in the lungs. As currently available treatments are unable to restore lung function in patients, there is an urgent medical need for more effective drugs. Developing such drugs, however, is challenging because IPF has a complex pathogenesis. Emerging evidence indicates that heat shock protein 47 (HSP47), which is encoded by the gene Serpinh1, may be a suitable therapeutic target as it is required for collagen synthesis. Pharmacological inhibition or knockdown of HSP47 could therefore be a promising approach to treat fibrosis. The objective of this study was to assess the therapeutic potential of Serpinh1-targeting small interfering RNA (siRNA) in fibrogenic precision-cut lung slices prepared from murine tissue. To enhance fibrogenesis, slices were cultured for up to 144 h with transforming growth factor β1. Self-deliverable siRNA was used to knockdown mRNA and protein expression, without affecting the viability and morphology of slices. After silencing HSP47, only the secretion of fibronectin was reduced while other aspects of fibrogenesis remained unaffected (e.g., myofibroblast differentiation as well as collagen secretion and deposition). These observations are surprising as others have shown that Serpinh1-targeting siRNA suppressed collagen deposition in animals. Further studies are therefore warranted to elucidate downstream effects on fibrosis upon silencing HSP47.
- Published
- 2021
- Full Text
- View/download PDF
20. Exploring interprofessional collaboration and attitudes of health sciences librarians
- Author
-
Rachel J. Hinrichs, Caitlin J. Bakker, Tara J. Brigham, Emily C. Ginier, Gregg A. Stevens, and Kristine M. Alpi
- Subjects
interprofessional education ,interprofessional collaboration ,health sciences librarians ,attitudes and perceptions ,survey ,Bibliography. Library science. Information resources ,Medicine - Abstract
Objective: This study assessed health sciences librarians’ attitudes toward interprofessional collaboration using the Interdisciplinary Education Perception Scale (IEPS) and gathered information on their involvement with interprofessional activities. Methods: The authors sent a survey to librarians in the Medical Library Association’s (MLA’s) Interprofessional Education Special Interest Group and Research Section consisting of the IEPS and questions about their prior and current experiences with interprofessional practice and education (IPE). We compared mean IEPS scores between each MLA group and several other demographic factors to assess differences in attitudes. We also compared librarians’ IEPS scores with those of previously published health professional students’ IEPS scores and thematically analyzed two open-ended questions. Results: Health sciences librarians’ scores on the IEPS indicated positive attitudes toward IPE. There were no statistically significant differences between any group. Health sciences librarians’ mean IEPS score was similar to the mean score of health professions students from a prior study. The most commonly reported interprofessional activity was teaching or facilitating learning activities for health professions students; fewer served on committees or engaged in non-curricular activities such as grand rounds and book clubs. Conclusion: Health sciences librarians in this study reported positive attitudes toward IPE, in line with the majority of other previously studied health professionals. Years of experience, previous health professional careers, and experience supporting IPE as a librarian had little bearing on the responses to the survey. This suggests that health sciences librarians have positive attitudes toward IPE, regardless of whether they directly support IPE programs or participate in interprofessional activities. This article has been approved for the Medical Library Association’s Independent Reading Program.
- Published
- 2020
- Full Text
- View/download PDF
21. Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
- Author
-
Daan van den Broek, T. Jeroen N. Hiltermann, Bonne Biesma, Winand N. M. Dinjens, Nils A. 't Hart, John W. J. Hinrichs, Mathie P. G. Leers, Kim Monkhorst, Matthijs van Oosterhout, Volkher Scharnhorst, Ed Schuuring, Ernst-Jan M. Speel, Michel M. van den Heuvel, Ron H. N. van Schaik, Jan von der Thüsen, Stefan M. Willems, Leonie de Visser, and Marjolijn J. L. Ligtenberg
- Subjects
predictive tumor markers ,carcinoma ,non-small cell lung ,molecular targeted therapy ,molecular pathology ,precision medicine ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The diagnostic landscape of non-small cell lung cancer (NSCLC) is changing rapidly with the availability of novel treatments. Despite high-level healthcare in the Netherlands, not all patients with NSCLC are tested with the currently relevant predictive tumor markers that are necessary for optimal decision-making for today's available targeted or immunotherapy. An expert workshop on the molecular diagnosis of NSCLC involving pulmonary oncologists, clinical chemists, pathologists, and clinical scientists in molecular pathology was held in the Netherlands on December 10, 2018. The aims of the workshop were to facilitate cross-disciplinary discussions regarding standards of practice, and address recent developments and associated challenges that impact future practice. This paper presents a summary of the discussions and consensus opinions of the workshop participants on the initial challenges of harmonization of the detection and clinical use of predictive markers of NSCLC. A key theme identified was the need for broader and active participation of all stakeholders involved in molecular diagnostic services for NSCLC, including healthcare professionals across all disciplines, the hospitals and clinics involved in service delivery, healthcare insurers, and industry groups involved in diagnostic and treatment innovations. Such collaboration is essential to integrate different technologies into molecular diagnostics practice, to increase nationwide patient access to novel technologies, and to ensure consensus-preferred biomarkers are tested.
- Published
- 2020
- Full Text
- View/download PDF
22. Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus
- Author
-
Yoshita Bhide, Jasmine Tomar, Wei Dong, Jacqueline de Vries-Idema, Henderik W. Frijlink, Anke Huckriede, and Wouter L. J. Hinrichs
- Subjects
whole inactivated influenza virus vaccine ,inhalation ,deposition ,immunogenicity ,protection ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Administration of influenza vaccines to the lungs could be an attractive alternative to conventional parenteral administration. In this study, we investigated the deposition site of pulmonary delivered liquid and powder influenza vaccine formulations and its relation to their immunogenicity and protective efficacy. In vivo deposition studies in cotton rats revealed that, the powder formulation was mainly deposited in the trachea ( ∼ 65%) whereas the liquid was homogenously distributed throughout the lungs ( ∼ 96%). In addition, only 60% of the antigen in the powder formulation was deposited in the respiratory tract with respect to the liquid formulation. Immunogenicity studies showed that pulmonary delivered liquid and powder influenza formulations induced robust systemic and mucosal immune responses (significantly higher by liquids than by powders). When challenged with a clinical isolate of homologous H1N1pdm virus, all animals pulmonary administered with placebo had detectable virus in their lungs one day post challenge. In contrast, none of the vaccinated animals had detectable lung virus titers, except for two out of eight animals from the powder immunized group. Also, pulmonary vaccinated animals showed no or little signs of infection like increase in breathing frequency or weight loss upon challenge as compared to animals from the negative control group. In conclusion, immune responses induced by liquid formulation were significantly higher than responses induced by powder formulation, but the overall protective efficacy of both formulations was comparable. Thus, pulmonary immunization is capable of inducing protective immunity and the site of antigen deposition seems to be of minor relevance in inducing protection.
- Published
- 2018
- Full Text
- View/download PDF
23. Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery
- Author
-
Annemarie Broesder, Said Y. Bircan, Anneko B. de Waard, Anko C. Eissens, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
ileo-colonic targeting ,film coating ,ColoPulse ,extrusion–spheronization ,pan coating ,ethanol ,Pharmacy and materia medica ,RS1-441 - Abstract
The ColoPulse coating is a pH-dependent coating that can be used to target drug release to the ileo-colonic region. ColoPulse coated tablets and capsules have demonstrated their targeting capabilities in vivo in more than 100 volunteers and patients. However, so far the ColoPulse coating has not been used for multi-particulate pellet formulations. The sulfasalazine–caffeine method can be used to confirm ileo-colonic drug delivery in vivo. Caffeine serves as a release marker in this method, while sulfasalazine serves as a marker for colonic arrival. In this study, extrusion–spheronization was used to produce microcrystalline cellulose based pellets containing both caffeine and sulfasalazine. Dissolution tests revealed that a superdisintegrant, i.e., croscarmellose sodium or sodium starch glycolate, should be incorporated in the formulation to achieve acceptable release profiles for both sulfasalazine and caffeine. However, acceptable release profiles were only obtained when the pelletizing liquid consisted of ethanol/water 1/1 (v/v) but not with pure water. This phenomenon was ascribed to the differences in the degree of swelling of the superdisintegrant in the pelletizing liquid during the granulation process. The pellets were coated with the ColoPulse coating and showed the desired pH-dependent pulsatile release profile in vitro. In future clinical studies, ileo-colonic targeting should be verified.
- Published
- 2021
- Full Text
- View/download PDF
24. Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen
- Author
-
Renée S. van der Kooij, Rob Steendam, Johan Zuidema, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
controlled release ,core-shell microspheres ,delayed pulsatile release ,microfluidics ,poly(dl-lactide-co-glycolide) ,single-injection vaccine ,Pharmacy and materia medica ,RS1-441 - Abstract
For many vaccines, multiple injections are required to confer protective immunity against targeted pathogens. These injections often consist of a primer administration followed by a booster administration of the vaccine a few weeks or months later. A single-injection vaccine formulation that provides for both administrations could greatly improve the convenience and vaccinee’s compliance. In this study, we developed parenterally injectable core-shell microspheres with a delayed pulsatile release profile that could serve as the booster in such a vaccine formulation. These microspheres contained bovine serum albumin (BSA) as the model antigen and poly(dl-lactide-co-glycolide) (PLGA) with various dl-lactide:glycolide monomer ratios as the shell material. Highly monodisperse particles with different particle characteristics were obtained using a microfluidic setup. All formulations exhibited a pulsatile in vitro release of BSA after an adjustable lag time. This lag time increased with the increasing lactide content of the polymer and ranged from 3 to 7 weeks. Shell thickness and bovine serum albumin loading had no effect on the release behavior, which could be ascribed to the degradation mechanism of the polymer, with bulk degradation being the main pathway. Co-injection of the core-shell microspheres together with a solution of the antigen that serves as the primer would allow for the desired biphasic release profile. Altogether, these findings show that injectable core-shell microspheres combined with a primer are a promising alternative for the current multiple-injection vaccines.
- Published
- 2021
- Full Text
- View/download PDF
25. Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems
- Author
-
Annemarie Broesder, Julia M. E. Berends, Sophie M. Scheepers, Duong N. Nguyen, Henderik W. Frijlink, and Wouter L. J. Hinrichs
- Subjects
ileo-colonic drug delivery ,supersaturation ,film coating ,BCS class II drug ,delayed release ,ColoPulse ,Pharmacy and materia medica ,RS1-441 - Abstract
Targeting celecoxib to the ileo-colonic region could be beneficial for the treatment and prevention of colon cancer. Ileo-colonic targeting can be achieved by using pH-dependent coating systems such as ColoPulse. Celecoxib has poor aqueous solubility, which may jeopardize optimal treatment. Therefore, we combined a pH-dependent coating with self-emulsifying drug delivery systems (SEDDS) or with solid dispersion systems (SD); two approaches that are often used to improve the dissolution behavior of lipophilic drugs. The dissolution behavior of various formulations of both systems was investigated. Optimized formulations with and without precipitation inhibitors were coated with the ColoPulse and the release of celecoxib was tested under non-sink conditions using an in vitro dissolution system, simulating the pH gradient of the gastrointestinal tract. The dissolution behavior of SDs with and without precipitation inhibitor (sodium dodecyl sulfate) and the SEDDS without precipitation inhibitor was negatively impacted by the coating. Control experiments indicated that components of the coating released in the dissolution medium acted as precipitation mediators. However, the SEDDS formulation with HPMC 4000 cps as a precipitation inhibitor showed excellent dissolution behavior. We hypothesize that HPMC accumulates at the oil/water interface of the emulsion thereby stabilizing the emulsion resulting in maintenance of the supersaturated state.
- Published
- 2021
- Full Text
- View/download PDF
26. Heparinumkehr mit Protamin nach perkutaner hepatischer Perfusion (PHP): Ist weniger mehr?
- Author
-
C Dewald, L Becker, F Wacker, R Brüning, and J Hinrichs
- Published
- 2023
27. Algorithmen für das Patientenmanagement bei lebensbedrohlichen spontanen Retroperitoneal- und Rektusscheidenblutungen (SRRSH): Erfahrungen aus drei Zentren
- Author
-
L S Becker, C Dewald, F Stoehr, R Kloeckner, B Meyer, F Wacker, and J Hinrichs
- Published
- 2023
28. Beyond the Conference: Health Sciences Librarians’ Motivations for Publishing
- Author
-
Rachel J. Hinrichs
- Subjects
General Medicine - Abstract
Introduction: Previous studies have found that only 21.8% to 28% of abstracts presented at the annual Medical Library Association (MLA) conferences are later published as journal articles. What motivates health sciences librarians to take the next step in publishing and disseminating their work? This study will answer the following questions: 1) Are librarians presenting at MLA conferences more motivated to publish due to internal motivational factors (e.g., “to build a professional reputation for myself”), external motivational factors (e.g., “I am expected to participate in research for my job”), or a mix of both? 2) Do motivations for publication differ between academic and hospital librarians? 3) Do motivations for publication differ between those who published in peer-reviewed journals and those who published in other venues? Methods: In this retrospective cohort study, the team surveyed first authors of abstracts presented at the MLA conferences in 2012 and 2014 to determine if they later published their work in any full-text format. If they did publish, the team asked authors where their work was published and the primary and secondary reasons for pursuing publication. The reasons for publication included internal and external motivational factors identified from the library science literature. Chi-square tests were used to assess differences in motivation. Results: One hundred and sixty one authors responded to the survey, and of these, 49 authors reported that they had published their abstract(s). Fifty-one percent (n=25) of respondents selected only internal motivational factors, 18.4% (n=9) selected only external motivational factors, and 30.6% (n=15) reported a mix of both. The author found no statistically significant differences between hospital and academic librarians, or those who published in peer-reviewed journals versus other venues. Discussion: Findings indicate that librarians who chose to publish their work after presenting at annual MLA conferences are primarily motivated to publish due to internal factors. Interventions designed to encourage MLA presenters to publish their work should consider ways to cultivate presenters’ internal motivation.
- Published
- 2023
29. Massage Therapy for Self-Management (PsycINFO)
- Author
-
Rachel J. Hinrichs
- Abstract
Used as part of a systematic review on massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions.
- Published
- 2023
30. Massage Therapy for Self-Management (Embase)
- Author
-
Rachel J. Hinrichs
- Abstract
Used as part of a systematic review on massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions.
- Published
- 2023
31. Massage Therapy for Self-Management (CINAHL)
- Author
-
Rachel J. Hinrichs
- Abstract
Used as part of a systematic review on massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions.
- Published
- 2023
32. Massage Therapy for Self-Management (Web of Science)
- Author
-
Rachel J. Hinrichs
- Abstract
Used as part of a systematic review on massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions.
- Published
- 2023
33. Massage Therapy for Self-Management (Google Scholar)
- Author
-
Rachel J. Hinrichs
- Abstract
Used as part of a systematic review on massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions.
- Published
- 2023
34. Skeletal Muscle and Chronic Kidney Disease (Medline)
- Author
-
Rachel J. Hinrichs
- Abstract
This is a broad search on skeletal muscle and chronic kidney disease. It was used in a systematic review called "Skeletal Muscle Atrophy in Clinical and Preclinical Models of CKD: A Systematic Review and Meta-Analysis.".
- Published
- 2023
35. Skeletal Muscle and Chronic Kidney Disease (Scopus)
- Author
-
Rachel J. Hinrichs
- Abstract
This is a broad search for articles on skeletal muscle and chronic kidney disease. It was used for a systematic review called "Skeletal Muscle Atrophy in Clinical and Preclinical Models of CKD: A Systematic Review and Meta-Analysis.".
- Published
- 2023
36. Skeletal Muscle and Chronic Kidney Disease (Embase)
- Author
-
Rachel J. Hinrichs
- Abstract
This is a broad search on skeletal muscle and chronic kidney disease. It was used for a systematic review called "Skeletal Muscle Atrophy in Clinical and Preclinical Models of CKD: A Systematic Review and Meta-Analysis".
- Published
- 2023
37. Development of an Orodispersible Film Containing Stabilized Influenza Vaccine
- Author
-
Yu Tian, Yoshita C. Bhide, Herman J. Woerdenbag, Anke L. W. Huckriede, Henderik W. Frijlink, Wouter L. J. Hinrichs, and J. Carolina Visser
- Subjects
whole inactivated influenza virus vaccine ,orodispersible films ,stabilization ,trehalose ,pullulan ,β-galactosidase ,hemagglutination ,Pharmacy and materia medica ,RS1-441 - Abstract
Most influenza vaccines are administered via injection, which is considered as user-unfriendly. Vaccination via oral cavity using an orodispersible film (ODF) might be a promising alternative. To maintain the antigenicity of the vaccine during preparation and subsequent storage of these ODFs, sugars such as trehalose and pullulan can be employed as stabilizing excipients for the antigens. In this study, first, β-galactosidase was used as a model antigen. Solutions containing β-galactosidase and sugar (trehalose or trehalose/pullulan blends) were pipetted onto plain ODFs and then either air- or vacuum-dried. Subsequently, sugar ratios yielding the highest β-galactosidase stability were used to prepare ODFs containing H5N1 whole inactivated influenza virus vaccine (WIV). The stability of the H5N1 hemagglutinin was assessed by measuring its hemagglutination activity. Overall, various compositions of trehalose and pullulan successfully stabilized β-galactosidase and WIV in ODFs. WIV incorporated in ODFs showed excellent stability even at challenging storage conditions (60 °C/0% relative humidity or 30 °C/56% relative humidity) for 4 weeks. Except for sugars, the polymeric component of ODFs, i.e., hypromellose, possibly improved stability of WIV as well. In conclusion, ODFs may be suitable for delivering of WIV to the oral cavity and can possibly serve as an alternative for injections.
- Published
- 2020
- Full Text
- View/download PDF
38. Leveraging 2nd life as a communications media: An effective tool for security awareness training.
- Author
-
Barbara Endicott-Popovsky, Randy J. Hinrichs, and Deborah A. Frincke
- Published
- 2013
- Full Text
- View/download PDF
39. Dietetic interns’ perceptions and use of evidence-based practice: an exploratory study
- Author
-
Rachel J. Hinrichs
- Subjects
Evidence-Based Practice ,Attitude of Health Personnel ,Dietetics ,Internships, Nonmedical ,Bibliography. Library science. Information resources ,Medicine - Abstract
Objective: This study explored dietetic interns’ perceptions and knowledge of evidence-based practice (EBP), their use and observation of EBP principles during their clinical rotations, and their intentions to use EBP in their careers. Methods: A mixed methods design combining a survey and focus group was employed. Dietetic interns (n=16) from a large Midwestern university were recruited in person and via email to participate in the survey, focus group, or both. Perceptions and experiences of EBP were analyzed through the focus group (qualitative), and EBP knowledge and clinical practice behaviors were analyzed through the survey (quantitative). The focus group discussion was recorded, transcribed, and analyzed using thematic analysis. Results: Four major themes emerged from the focus group data: (1) observations of EBP in clinical practice, (2) use of EBP during clinical rotations, (3) barriers to EBP, and (4) perceived use of EBP as future registered dietitians. Interns considered EBP important for their profession and future careers. They struggled, however, with the discrepancies between current research and practice, and highlighted differences that they observed and barriers that they experienced across different clinical settings. Conclusions: This exploratory study is the first to examine dietetic interns’ perceptions of and experiences with EBP in the clinical setting. Future research is needed to identify how dietetics educators, librarians, and preceptors can address the barriers that interns perceive in applying EBP in their internships.
- Published
- 2018
- Full Text
- View/download PDF
40. Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
- Author
-
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, and Lieven Baert
- Subjects
Medicine ,Science - Abstract
A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this study we investigated whether a core-shell based implant, containing ovalbumin as core material and poly(DL-lactic-co-glycolic acid) of various monomer ratios as shell material can be used to obtain such a booster release. An in vitro release study showed that the lag time after which the ovalbumin was released from the core-shell implant increased with increasing lactic to glycolic acid ratio of the polymer and ranged from 3-6 weeks. Fluorescence spectroscopy showed minimal differences between native ovalbumin and ovalbumin from core-shell implants that were incubated until just before the observed in vitro release. In addition, mice immunized with a subcutaneous inserted core-shell implant containing ovalbumin showed an ovalbumin-specific IgG1 antibody response after a lag time of 4 or 6-8 weeks. Moreover, delayed release of ovalbumin caused higher IgG1 antibody titers than conventional subcutaneous vaccination with ovalbumin dissolved in PBS. Collectively, these findings could contribute to the further development of a single-injection vaccine, making multiple injections of the vaccine superfluous.
- Published
- 2018
- Full Text
- View/download PDF
41. Stellenwert der Rezidivoperation beim adulten Granulosazelltumor des Ovars
- Author
-
S Kaiser, P Harter, F Heitz, T Westermann, J Welz, R Schwameis, N Concin, M Imetrat, A Strojna, T Dagres, V Vrentas, J Hinrichs, S Boland, N Pauly, S Heikaus, M Moubarak, A Traut, and B Ataseven
- Published
- 2022
42. Effektivitätsanalyse eines 3D Bewegungskorrekturalgorithmus in während transarterieller Chemoembolisation akquirierter C-Arm Computertomographien mit eingeschränkter diagnostischer Bildqualität
- Author
-
S L Becker, C von Falck, C Dewald, T Werncke, S Maschke, B Meyer, F Wacker, and J Hinrichs
- Published
- 2022
43. Quantitativer Washout bei Patienten mit hepatozellulärem Karzinom und transarterieller Chemoembolisation: Ein bildgebender Biomarker für die Prognosevorhersage?
- Author
-
L Müller, F Hahn, F Jungmann, A Mähringer-Kunz, F Stöhr, M Halfmann, D Pinto dos Santos, J Hinrichs, A T Auer, C Düber, and R Kloeckner
- Published
- 2022
44. Suicide Prevention and College Students (Google Scholar)
- Author
-
Rachel J. Hinrichs
- Abstract
Google scholar search on prevention interventions for suicide in college students.
- Published
- 2022
45. Suicide Prevention Among College Students Before and During the COVID-19 Pandemic (Medline)
- Author
-
Rachel J. Hinrichs
- Abstract
This search includes the concepts of college students, suicide, and intervention/prevention. In keeping with the health equity focus of the review, terms related to potentially under-resourced college populations, such as nontraditional, commuter, foreign, international, or first-generation, were included. Terms for prevention were purposely kept broad to encompass a wide range of possible interventions.
- Published
- 2022
46. Effect of dietary nitrate on human muscle power (Scopus)
- Author
-
Rachel J. Hinrichs
- Abstract
Scopus search for muscle power and dietary nitrate/beetroot.
- Published
- 2022
47. Combining Nonclinical Determinants of Health and Clinical Data for Research and Evaluation (Medline)
- Author
-
Rachel J. Hinrichs
- Abstract
This is a Medline search string for a rapid review of social determinants of health used in conjunction with clinical data sources such as electronic health records.
- Published
- 2022
48. College Students and Suicide Prevention (Scielo)
- Author
-
Rachel J. Hinrichs
- Abstract
This search includes the concepts of college students, suicide, and intervention/prevention. In keeping with the health equity focus of the review, terms related to potentially under-resourced college populations, such as nontraditional, commuter, foreign, international, or first-generation, were included. Terms for prevention were purposely kept broad to encompass a wide range of possible interventions.
- Published
- 2022
49. Effect of dietary nitrate on human muscle power (Clinicaltrials.gov)
- Author
-
Rachel J. Hinrichs
- Abstract
Clinicaltrials.gov search for muscle power and dietary nitrate/beetroot.
- Published
- 2022
50. Effect of dietary nitrate on human muscle power (Embase)
- Author
-
Rachel J. Hinrichs
- Abstract
Embase search on human muscle power and beetroot/NO3-/dietary nitrate.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.